DOI: 10.1055/s-00000069

Seminars in Liver Disease

Referenz


A phase III randomized, double-blind trial of chemoembolization with or without sorafenib in unresectable hepatocellular carcinoma (HCC) in patients with and without vascular invasion.
Available at:
http://clinicaltrials.gov/ct2/show/NCT01004978 . Accessed February 23, 2012

Bibliographische Angaben herunterladen

Suchen in: